Prime vendor pharm branch-philadelphia
Ended Indefinite Delivery Contract Awarded
- Contract number
- SPE2DB22D9209
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 149 $487,304 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $487,304 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $499,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies on an as-needed basis. The contract has a potential value of $499,999,999 and a period of performance through December 31, 2025.
Task orders issued against the contract by DLA between January 18, 2023 and August 30, 2022 require DMS Pharmaceutical to deliver a variety of pharmaceutical products to locations in Park Ridge, Illinois. These products include medications such as Botox, Nexplanon implants, antibiotics, anti-itch cream, and others. The task orders range in value from $16 to over $2 million and utilize firm fixed price terms, with periods of performance varying from one to over twenty days. No set-aside provisions or subcontracting requirements were specified in the materials provided.
As the prime vendor, DMS Pharmaceutical Group Inc. will supply pharmaceuticals and medical consumables to support the Defense Logistics Agency's global logistics operations. DLA is responsible for procuring and distributing these critical supplies to military treatment facilities and contingency environments worldwide. The task orders awarded appear to replenish standard pharmaceutical inventory levels and fulfill ongoing treatment needs within the military health system, in line with DLA's mission to ensure materiel readiness for all military services.
Task orders
Show 40 more
Latest 50 of 149 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DB22D9209?
SPE2DB22D9209 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 23, 2022.
How much is contract SPE2DB22D9209 worth?
Orders under SPE2DB22D9209 have obligated $487,304. SPE2DB22D9209's own ceiling is $499,999,999.
How many orders have been placed under contract SPE2DB22D9209?
149 orders have been placed under SPE2DB22D9209, the latest on September 26, 2025.
Who can order from contract SPE2DB22D9209?
SPE2DB22D9209 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB22D9209 competed?
The extent of competition for SPE2DB22D9209 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV